Deubiquitinating enzyme USP22 positively regulates c-Myc stability and tumorigenic activity in mammalian and breast cancer cells. (Q50912096)

25 March 2018

title

Deubiquitinating enzyme USP22 positively regulates c-Myc stability and tumorigenic activity in mammalian and breast cancer cells. (English)

1 reference

25 March 2018

author name string

Dongyeon Kim

1

1 reference

25 March 2018

Ahyoung Hong

2

1 reference

25 March 2018

Hye In Park

3

1 reference

25 March 2018

Woo Hyun Shin

4

1 reference

25 March 2018

Lang Yoo

5

1 reference

25 March 2018

Seo Jeong Jeon

6

1 reference

25 March 2018

Kwang Chul Chung

7

1 reference

25 March 2018

publication date

4 February 2017

1 reference

25 March 2018

Journal of Cellular Physiology

published in

1 reference

25 March 2018

volume

232

1 reference

25 March 2018

issue

12

1 reference

25 March 2018

page(s)

3664-3676

1 reference

25 March 2018

Transcriptional regulation and transformation by Myc proteins

cites work

1 reference

The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis

21 January 2018

1 reference

USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1

21 January 2018

1 reference

Gcn5 and SAGA regulate shelterin protein turnover and telomere maintenance.

21 January 2018

1 reference

ELL targets c-Myc for proteasomal degradation and suppresses tumour growth

21 January 2018

1 reference

c-Myc target genes involved in cell growth, apoptosis, and metabolism

21 January 2018

1 reference

Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival

21 January 2018

1 reference

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

21 January 2018

1 reference

21 January 2018

1 reference

Choosing the right cell line for breast cancer research

21 January 2018

1 reference

Ubiquitin-specific protease 22 (USP22) positively regulates RCAN1 protein levels through RCAN1 de-ubiquitination

21 January 2018

1 reference

Assembly of b/HLH/z proteins c-Myc, Max, and Mad1 with cognate DNA: importance of protein-protein and protein-DNA interactions

21 January 2018

1 reference

Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.

21 January 2018

1 reference

Inhibition of Ubiquitin-specific Peptidase 8 Suppresses Growth of Gefitinib-resistant Non-small Cell Lung Cancer Cells by Inducing Apoptosis

21 January 2018

1 reference

The F-box protein FBXO7 positively regulates bone morphogenetic protein-mediated signaling through Lys-63-specific ubiquitination of neurotrophin receptor-interacting MAGE (NRAGE).

21 January 2018

1 reference

Deubiquitinating enzymes as cellular regulators

21 January 2018

1 reference

Ubiquitin-specific protease 22 is a deubiquitinase of CCNB1.

21 January 2018

1 reference

USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development.

21 January 2018

1 reference

Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer

21 January 2018

1 reference

Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells

21 January 2018

1 reference

FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity

21 January 2018

1 reference

Ubiquitin-specific peptidase 22 functions and its involvement in disease

21 January 2018

1 reference

USP2a activation of MYC in prostate cancer

21 January 2018

1 reference

Deubiquitinases and the new therapeutic opportunities offered to cancer

21 January 2018

1 reference

USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma

21 January 2018

1 reference

Polyubiquitin chains: polymeric protein signals

21 January 2018

1 reference

The ubiquitin-specific protease USP28 is required for MYC stability

21 January 2018

1 reference

SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway

21 January 2018

1 reference

MYC is a metastasis gene for non-small-cell lung cancer

21 January 2018

1 reference

MYC overexpression and poor prognosis in sporadic breast cancer with BRCA1 deficiency

21 January 2018

1 reference

USP22 regulates oncogenic signaling pathways to drive lethal cancer progression

21 January 2018

1 reference

Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

21 January 2018

1 reference

High USP22 expression indicates poor prognosis in hepatocellular carcinoma.

21 January 2018

1 reference

Ubiquitin and ubiquitin-like proteins as multifunctional signals

21 January 2018

1 reference

The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation

21 January 2018

1 reference

21 January 2018

1 reference

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

21 January 2018

1 reference

Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7

21 January 2018

1 reference

Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics.

21 January 2018

1 reference

The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCP.25841

1 reference

25 March 2018

PubMed ID

28160502

1 reference

25 March 2018